AzTrials
AzTrials

Visual FatigueALGO-HMDNCT05243277

Oculomotor Response While Using a Helmet Display Incorporating an Accommodation-vergence Stress Reduction Algorithm

An observational study of Visual Fatigue, run by Direction Centrale du Service de Santé des Armées at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Operational military personnel are increasingly using virtual or augmented reality headsets in the field or in training. However, these devices cause a conflict between accommodation (focus to see clearly) and vergence (alignment of both eyes on the object being viewed) that can be a source of visual fatigue and… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Visual Fatigue
What is being tested?
Oculomotor tests
How many people
30 participants
Where
1 siteFrance
Study dates
16 Mar 2023to 16 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The study population is composed of healthy subjectfs with no history of visual disorders.

Who may be able to join

  • Age over 18
  • Non-presbyopic
  • Stereoscopic acuity ≤ 60 min of arc

Who cannot join

  • Accommodative insufficiency (APP ≤ 13-"age"/4, in diopters)
  • Accommodative inertia (+ and - block in binocular)
  • Compensation by orthokeratology
  • Present or past binocular pathology: strabismus or amblyopia

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Institut de Recherche Biomédicale des Armées

    Brétigny-sur-Orge, 91223

    Pascaline NEVEU, PhD, 178651212 ext. +33, pascaline.neveu@intradef.gouv.fr

    Recruiting

Other trials in France

About this study

Operational military personnel are increasingly using virtual or augmented reality headsets in the field or in training. However, these devices cause a conflict between accommodation (focus to see clearly) and vergence (alignment of both eyes on the object being viewed) that can be a source of visual fatigue and altered visual and perceptual abilities. Although techniques exist to limit this conflict for screen-based stimuli, the use of helmet visuals (or immersive headsets) adds technological complexity. Indeed, since accommodation on the screen of the helmet visual is impossible (i.e., distance too small) for the human visual system, lenses are used to virtually shift the image (referred to as a collimated image) so that accommodation can occur much further away. However, this material configuration also modifies the vergence, thus causing a conflict between accommodation and additional vergence that persists regardless of the attenuation technique used.

In this study, the investigator proposed to modify the image display to take into account the technical features of the helmet to correct this techno-dependent conflict. This study is aimed at determining whether the setting recommended by the algorithm developed by the investigator limits visual fatigue better than the conventional setting recommended by manufacturers or a subjective setting controlled by the user.

Conditions
Visual Fatigue
Being tested
Oculomotor tests
Keywords
virtual reality
Medical subject headings
Asthenopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oculomotor testsOther

    There will be four visits. Each visit is associated with a different exposure in terms of level of oculomotor conflict.

    At each visit, several oculomotor tests will be performed, followed by a comfort questionnaire. The oculomotor tests are subjective tests during which the participant will be asked to fix his/her eyes on one or more targets that can move in space and to indicate the way he/she perceives this/these target(s). Depending on the test, lenses may be inserted between the participant and the target to modify his/her perception.

    The comfort questionnaire consists to rate on a scale of 1 (not at all) to 5 (very much) the presence of visual symptoms, such as burning, watering or dryness.

    The participant will then have to perform four different perceptual tasks. His/her level of accommodation (i.e. focus) will be monitored throughout the tasks.

    Each exposure is followed again by eye tests and a comfort questionnaire.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evolution of oculomotor response to a stimulation generating jumps in vergence demand

    Oculomotor response (accommodation and vergence) will be measured continuously via a single objective system (PowerRef 3) at each visit.

    Measured: Until the end of the study (20 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2022
  2. Study start16 Mar 2023
  3. Primary completion16 Dec 2024 (estimated)
  4. Study completion16 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05243277
Sponsor's protocol ID
2021PBMD04
Other IDs
2021-A02286-35
Acronym
ALGO-HMD
Status last verified
Mar 2023
First submitted
8 Dec 2021
Last updated
28 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Visual Fatigue, run by Direction Centrale du Service de Santé des Armées at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pascaline NEVEU, PhD (178651212 ext. +33, pascaline.neveu@intradef.gouv.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evolution of oculomotor response to a stimulation generating jumps in vergence demand (time frame: Until the end of the study (20 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in